LOX and breast cancer: The currently used animal model was previously successfully utilized by our group in experiments in which maternal diet supplementation with CLA caused a lower susceptibility to mammary tumors in female offspring as well as influencing n-3 and n-6 PUFA and their lipoxygensae (LOX) metabolites concentrations in serum [41,54].